News from Friday, September 27, 2024
Articles
New Report Highlights Data-Driven Success Strategies for ACOs
(9/26, Hayden E. Klein, The American Journal of Managed Care) reports “A new report from the National Association of Accountable Care Organizations (NAACOS) shed light on the strategies that have driven the success of ACOs in adopting value-based care (VBC). Based on in-depth interviews with high-performing ACOs, the September 2024 ACO Drivers for Success report outlines 5 core strategies for effective ACO management, including working across payers, fostering a high-value culture, leveraging data, implementing clinical interventions, and engaging patients.” Full
England’s NICE Says Severity Modifier Working, But Industry Wants Cost Restrictions Lifted
(9/27, Eliza Slawther, Pink Sheet) reports “...The UK government should remove a cost-neutrality restriction on England’s health technology assessment institute, NICE, that limits the value it places on medicines for severe conditions, says industry body the ABPI.” Subscription Required
GetReal Conference 2024: Insights from Session 7 – Aligning Stakeholder Needs in Regulatory and HTA Decisions Using RWE
(9/27, The Evidence Base) reports “The final session of the GetReal Conference 2024, moderated by Niklas Hedberg, brought together a diverse panel of stakeholders to reflect on the event’s key discussions. The panel outlined priorities for advancing the use of real-world data (RWD) and real-world evidence in health care, emphasizing collaboration, transparency, and practical actions moving forward.” Full
Journals
Going Beyond Randomised Controlled Trials to Assess Treatment Effect Heterogeneity Across Target Populations
David G Lugo-Palacios, et al.
September 26, 2024, Health Economics
Guiding Principles for Evaluating Vaccines in Joint Health Technology Assessment in the European Union: Preparing for the European Union’s Regulation on Health Technology Assessment for Vaccines
Nathalie Largeron PharmD, et al.
October 2024, Value in Health